Details for New Drug Application (NDA): 206126
✉ Email this page to a colleague
The generic ingredient in ETOMIDATE is etomidate. There are six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the etomidate profile page.
Summary for 206126
Tradename: | ETOMIDATE |
Applicant: | Eugia Pharma |
Ingredient: | etomidate |
Patents: | 0 |
Pharmacology for NDA: 206126
Physiological Effect | General Anesthesia |
Medical Subject Heading (MeSH) Categories for 206126
Suppliers and Packaging for NDA: 206126
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ETOMIDATE | etomidate | INJECTABLE;INJECTION | 206126 | ANDA | HF Acquisition Co LLC, DBA HealthFirst | 51662-1542 | 51662-1542-1 | 20 mL in 1 VIAL, SINGLE-DOSE (51662-1542-1) |
ETOMIDATE | etomidate | INJECTABLE;INJECTION | 206126 | ANDA | HF Acquisition Co LLC, DBA HealthFirst | 51662-1634 | 51662-1634-1 | 10 mL in 1 VIAL, SINGLE-DOSE (51662-1634-1) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 2MG/ML | ||||
Approval Date: | Feb 24, 2017 | TE: | AP | RLD: | No |
Complete Access Available with Subscription